Merck & Co's Gardasil adds US indication for boys and men
This article was originally published in Scrip
Executive Summary
Merck & Co's human papillomavirus vaccine Gardasil has extended its US label to include use in boys and men. On October 16th, the FDA approved a new indication in males aged nine to 26 years to prevent genital warts caused by HPV types 6 and 11.